Does the Intersectionality of Race/Ethnicity and Type 2 Diabetes Increase the Odds of a Cervical Cancer Diagnosis? A Nested Case–Control Study of a Florida Statewide Multisite EHR Database
暂无分享,去创建一个
Yi Guo | E. Shenkman | Ji Hyun Lee | Stephanie A. S. Staras | D. Avery | R. Mkuu | J. Higginbotham | Zhanna Galochkina | H. Cho | Jaclyn M Hall | Choeeta Chakrabarti | Sable Bowman Barrow | Selena Ortega | J. Lockhart
[1] D. Kapp,et al. The increasing incidence of stage IV cervical cancer in the USA: what factors are related? , 2022, International Journal of Gynecological Cancer.
[2] Eric A. Miller,et al. Cervical cancer screening and predictors of screening by diabetes status , 2022, Cancer Causes & Control.
[3] L. Thorpe,et al. 1262-P: Developing a Computable Phenotype Algorithm for Identification of Children and Adolescents with Diabetes Using Electronic Health Records , 2022, Diabetes.
[4] E. Shenkman,et al. Clinicians’ perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study , 2022, BMC cancer.
[5] Chiahung Chou,et al. Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South , 2021, Cancers.
[6] P. Austin,et al. Periodic screening for breast and cervical cancer in women with diabetes: a population-based cohort study , 2021, Cancer Causes & Control.
[7] M. Vanstone,et al. Understanding Black Women's Perspectives and Experiences of Cervical Cancer Screening: A Systematic Review and Qualitative Meta-synthesis , 2021, Journal of health care for the poor and underserved.
[8] Tonatiuh V Mendoza,et al. The OneFlorida Data Trust: a centralized, translational research data infrastructure of statewide scope , 2021, J. Am. Medical Informatics Assoc..
[9] J. Trogdon,et al. Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination , 2021, Cancer Epidemiology, Biomarkers & Prevention.
[10] M. Gunter,et al. Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies , 2021, Cancer Epidemiology, Biomarkers & Prevention.
[11] Kanan T. Desai,et al. A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer. , 2021, Preventive medicine.
[12] A. Odoi,et al. Investigation of geographic disparities of pre-diabetes and diabetes in Florida , 2020, BMC Public Health.
[13] C. Flowers,et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society , 2020, CA: a cancer journal for clinicians.
[14] S. Larsson,et al. Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study , 2020, Diabetes.
[15] S. Saydah,et al. Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016. , 2019, JAMA.
[16] M. White,et al. Rural–Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010–2014 , 2019, Preventing chronic disease.
[17] S. Sulaiman,et al. Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability , 2019, Scientific Reports.
[18] S. Sulaiman,et al. Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability , 2019, Scientific Reports.
[19] Kelly L. Reburn,et al. Cervical Cancer Screening Behaviors and Perceptions of Medical Mistrust among Rural Black and White Women , 2018, Journal of health care for the poor and underserved.
[20] W. Hogan,et al. Characterization of adult obesity in Florida using the OneFlorida clinical research consortium , 2018, Obesity science & practice.
[21] A. Lenzi,et al. Linking type 2 diabetes and gynecological cancer: an introductory overview , 2018, Clinical chemistry and laboratory medicine.
[22] Xianquan Zhang,et al. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients , 2017, Medicine.
[23] J. King,et al. Understanding Barriers to Cervical Cancer Screening in Women With Access to Care, Behavioral Risk Factor Surveillance System, 2014 , 2016, Preventing chronic disease.
[24] P. Sasieni,et al. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study , 2016, British Journal of Cancer.
[25] D. W. Perkins,et al. Racial and Economic Disparities in Diabetes in a Large Primary Care Patient Population. , 2016, Ethnicity & disease.
[26] F. Guo,et al. Effects of Cardiovascular Disease on Compliance with Cervical and Breast Cancer Screening Recommendations Among Adult Women. , 2015, Journal of women's health.
[27] Jae-Wook Jeong,et al. The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms , 2015, BioMed research international.
[28] Roland J Thorpe,et al. Disparities in diabetes: the nexus of race, poverty, and place. , 2014, American journal of public health.
[29] D. Lieberman,et al. The Association of Type and Number of Chronic Diseases with Breast, Cervical, and Colorectal Cancer Screening , 2014, The Journal of the American Board of Family Medicine.
[30] T. Mangione,et al. Barriers to cervical cancer screening and follow-up care among Black Women in Massachusetts. , 2014, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.
[31] S. Stokley,et al. Delay and Refusal of Human Papillomavirus Vaccine for Girls, National Immunization Survey–Teen, 2010 , 2014, Clinical pediatrics.
[32] 地理学. United States Census Bureau , 2011 .
[33] K. Richardson,et al. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias , 2011, Diabetologia.
[34] J. Webber. Center , 2011 .
[35] D. Harlan,et al. Diabetes and Cancer , 2010, Diabetes Care.
[36] Laura Sciacca,et al. Diabetes and cancer. , 2009, Endocrine-related cancer.
[37] Louette R. Johnson Lutjens. Research , 2006 .
[38] J. Schulman,et al. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[39] Paul R. Rosenbaum,et al. Optimal Matching for Observational Studies , 1989 .
[40] Michigan.,et al. Toxicological profile for dichloropropenes , 2008 .